The Drug-Induced Cardiotoxicity Website and App

I. Myocardial dysfunction - Heart failure

I.a Left or biventricular dysfunction/failure

I. Myocardial dysfunction - Heart failure

I.c Heart failure (biventricular, congestive)

I. Myocardial dysfunction - Heart failure

I.d Cardiovascular collapse - Cardiogenic shock - Hypotension

I. Myocardial dysfunction - Heart failure

I.e Acute respiratory or cardiopulmonary failure

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.f Tachycardia

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.g QTc prolongation

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.l Cardiac- cardiorespiratory/pulmonary arrest

III. Myocardial ischemia - Coronary artery disease

III.c Coronary vasospasm - Vasospastic angina

III. Myocardial ischemia - Coronary artery disease

III.g ST segment changes

VI. Cardiomyopathy

VI.a Cardiomyopathy (acute, subacute, chronic)

VII. Cardiotoxicity

VII.a Cardiotoxicity

X. Pulmonary edema - ALI/ARDS

X.b Pulmonary edema, noncardiogenic (NCPE)

X. Pulmonary edema - ALI/ARDS

X.c Interstitial pulmonary edema

XII. Pericardial involvement

XII.b Pericardial effusion (w/wo tamponade)

XIII. Thrombosis - Embolism

XIII.a Pulmonary embolism - Venous thrombosis/thromboembolism

XIV. Pleural involvement

XIV.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

XVI. Hemorrhage - Bleeding - Hematoma

XVI.i Hemoptysis

XXII. Acute respiratory/cardiorespiratory failure

XXII.b ARDS - Acute lung injury

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.l Pulmonary infiltrates

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.y Cytokine release syndrome - Cytokine storm